View Author
scopus: 34572186500

Ninomiya, T.

(T. Ninomiya)


patient study treatment treatment bene fit effect perindopril hypertension score progress disease receptor polymorphism analysis blood pressure association treatment effect europa therapy blood pressure inhibitor pergene artery disease ace-inhibitor response signi population reduction trial table erasmus universiteit rotterdam allele fi ndings system pharmacogenetic placebo interaction ace inhibitors body mass index value artery bene fit heart rotterdam haplotype enzyme nding pharmacogenetic score bp response genotype group p-value renin pathway determinant odds ratio blood pressure response brugt ficant variation result europa-trial sample ratio event 1.00 agt gene signi ficantly signi ficant erasmu research bp reduction simoons ml ace-inhibitor therapy model angiotensinogen william p values angiotensin-converting enzyme bradykinin




2 Most Recent Publications

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (Article)
Brugts, J.J. Isaacs, A. Remme, W.J. Bertrand, M.E. Ninomiya, T. Harrap, S. Chalmers, J. MacMahon, S. Fox, K. Ferrari, R. Simoons, M.L. Danser, A.H.J. Maat, M.P.M. de Boersma, E.R. Duijn, C.M. van Akkerhuis, K.M. Uitterlinden, A.G. Witteman, J.C.M. Cambien, F. Ceconi, C.
2011-03-01
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease (Article)
Brugts, J.J. Isaacs, A.J. MacMahon, S. Fox, K.M. Ferrari, R. Witteman, J.C.M. Danser, A.H.J. Simoons, M.L. Maat, M.P.M. de Boersma, E.R. Duijn, C.M. van Uitterlinden, A.G. Remme, W.J. Bertrand, M.E. Ninomiya, T. Ceconi, C. Chalmers, J.
2010-08-01